Alpha Healthcare Acquisition Corp. (AHAC)
|Net Income (ttm)||-878|
|Trading Day||March 5|
|Day's Range||10.07 - 10.85|
|52-Week Range||9.65 - 16.96|
Why Humacyte Is Going Public Via SPAC
Feb.17 -- Dr. Laura Niklason, chief executive officer and founder of Humacyte, discusses the biotech company's decision to go public through a merger with Alpha Healthcare Acquisition Corp., a...
Humacyte is a leader in regenerative medicine, growing human tissue in the lab that can be transplanted into any patient.
Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.
NEW YORK and DURHAM, N.C., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company led by Mr. Rajiv Shukla, today an...
Alpha Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing November 9, 2020
NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (the “Company”) announced today that holders of the units sold in the Company's initial public offering of 10,000...
New York, NY, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (NASDAQ: AHACU) (the “Company”) announced today that it closed its initial public offering of 10,000,000 u...
New York, NY, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at $10.00 p...
Alpha Healthcare Acquisition is a newly organized blank check company formed as a Delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business c... [Read more...]
|IPO Date |
Sep 18, 2020
Rajiv Sarman Shukla
|Stock Exchange |
|Ticker Symbol |